Literature DB >> 18585035

T-type Ca2+ channel blockers suppress the growth of human cancer cells.

Jae Ho Heo1, Han Na Seo, Yun Jeong Choe, Sujin Kim, Chun Rim Oh, Young Deuk Kim, Hyewhon Rhim, Dong Joon Choo, Jungahn Kim, Jae Yeol Lee.   

Abstract

In order to further clarify the role of T-type Ca(2+) channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca(2+) channel blockers. As a result, KYS05090, a most potent T-type Ca(2+) channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca(2+) channel blocker presents new prospects for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585035     DOI: 10.1016/j.bmcl.2008.06.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

Review 1.  T-type calcium channels blockers as new tools in cancer therapies.

Authors:  Barbara Dziegielewska; Lloyd S Gray; Jaroslaw Dziegielewski
Journal:  Pflugers Arch       Date:  2014-01-22       Impact factor: 3.657

2.  Triflic anhydride mediated synthesis of 3,4-dihydroquinazolines: a three-component one-pot tandem procedure.

Authors:  Christina L Magyar; Tyler J Wall; Steven B Davies; Molly V Campbell; Haven A Barna; Sydney R Smith; Christopher J Savich; R Adam Mosey
Journal:  Org Biomol Chem       Date:  2019-08-28       Impact factor: 3.876

3.  Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation.

Authors:  Viktor Yarotskyy; Keith S Elmslie
Journal:  J Pharmacol Exp Ther       Date:  2011-11-16       Impact factor: 4.030

4.  Friedel-Crafts synthesis of bis(trifluoromethylated)-4-aryl-3,4-dihydroquinazolines, bis(trifluoromethylated)-3,4-dihydroquinazoline-4-ols and trifluoromethyl arylketoimines using N-aryltrifluoroacetimidoyl chlorides and benzene derivatives.

Authors:  Elham Kazemi; Ali Darehkordi; Alireza Abbasi
Journal:  Mol Divers       Date:  2021-02-03       Impact factor: 2.943

Review 5.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01

6.  T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines.

Authors:  Weifeng Huang; Chunjing Lu; Yong Wu; Shou Ouyang; Yuanzhong Chen
Journal:  J Exp Clin Cancer Res       Date:  2015-05-21

7.  Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.

Authors:  Lorenzo Fornaro; Caterina Vivaldi; Dong Lin; Hui Xue; Alfredo Falcone; Yuzhuo Wang; Francesco Crea; Martin D Bootman
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

8.  Syntheses of 3,4- and 1,4-dihydroquinazolines from 2-aminobenzylamine.

Authors:  Jimena E Díaz; Silvia Ranieri; Nadia Gruber; Liliana R Orelli
Journal:  Beilstein J Org Chem       Date:  2017-07-27       Impact factor: 2.883

9.  Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels.

Authors:  Hayley Duckles; Hannah E Boycott; Moza M Al-Owais; Jacobo Elies; Emily Johnson; Mark L Dallas; Karen E Porter; Francesca Giuntini; John P Boyle; Jason L Scragg; Chris Peers
Journal:  Pflugers Arch       Date:  2014-04-18       Impact factor: 3.657

10.  Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.

Authors:  Elia Ranzato; Simona Martinotti; Valeria Magnelli; Bruno Murer; Stefano Biffo; Luciano Mutti; Bruno Burlando
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.